Kenneth Washkau

Kenneth Washkau, PharmD, currently serves as Associate Director and Senior Medical Science Liaison in Oncology at Incyte Corporation since June 2014, focusing on the development of small molecule and immuno-oncology assets. Key contributions include facilitating Material Transfer Agreements for preclinical collaborations, nurturing strong relationships with Key Opinion Leaders, and providing clinical trial support across various phases. Previous experience at Bayer HealthCare Pharmaceuticals included roles as a Medical Science Liaison, where responsibilities spanned supporting clinical trials and pipeline activities, and as a Liver Disease Specialist, collaborating with multidisciplinary teams for hepatocellular carcinoma treatment. Kenneth Washkau began the career in oncology sales, engaging with hematology and oncology physicians regarding monoclonal antibody therapies. Kenneth holds a PharmD from the University of Kansas.